LakeShore Biopharma Co., Ltd.
corporate_fare Company Profile
LakeShore Biopharma Co., Ltd. (OTC:LSBCF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for LSBCF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-24, rated 10/10. Across its 11 most recent items scored 7 or higher, the top rating is 10/10, with 10 rated 8 or above. Recent SEC coverage for LSBCF spans SC 13E3/A, 6-K, SCHEDULE 13D/A.
Recent high-impact activity:
- LakeShore Biopharma Completes Going-Private Merger, Shares to Be Delisted
- LakeShore Biopharma Completes Going-Private Transaction at $0.066 Per Share
- LakeShore Biopharma Completes Going-Private Merger, Shareholders to Receive $0.066/Share
- LakeShore Biopharma Shareholders Approve Go-Private Merger Agreement
- LakeShore Biopharma Sets Shareholder Meeting to Vote on Going-Private Merger
Financial Snapshot
Insider Transactions
LSBCF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.